Library Screening to Identify Highly-Effective Autophagy Inhibitors for Improving Photothermal Cancer Therapy

Nano Lett. 2021 Nov 24;21(22):9476-9484. doi: 10.1021/acs.nanolett.1c02825. Epub 2021 Nov 3.

Abstract

The small molecular inhibitor-associated downregulation of autophagy can remarkably enhance the efficiency of photothermal cancer therapy. To identify a more effective autophagy inhibitor, we screened a library of 20 compounds and found chloroquine, hydroxychloroquine, dauricine, and daurisoline were more efficient than the others to improve the photothermal killing of cancer cells. Interestingly, the four agents all disturb the autophagosome formation and fusion process, indicating it is a promising target to enhance cancer therapeutic efficiency. Among the four agents, daurisoline was identified to be the most efficient one. It reduced the viability of cancer cells treated by low-energy photothermal therapy from 86.27% to 32.92%. Finally, the combination treatment mediated by nanodrugs loaded with daurisoline and indocyanine green was more efficient than the individual modalities, resulting in complete inhibition of tumor growth. The study gives new inspiration to autophagy modulation-associated photothermal therapy and other therapeutic modalities for cancer treatment.

Keywords: autophagy inhibition; cancer; library screen; nanodrugs; photothermal therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Autophagy* / drug effects
  • Combined Modality Therapy
  • Humans
  • Neoplasms* / drug therapy
  • Neoplasms* / therapy
  • Photothermal Therapy*
  • Treatment Outcome

Substances

  • Antineoplastic Agents